Midkine, a heparin-binding growth factor, selectively stimulates proliferation of definitive zone cells of the human fetal adrenal gland

Hitoshi Ishimoto, Marcus O. Muench, Takayuki Higuchi, Kazuhiro Minegishi, Mamoru Tanaka, Yasunori Yoshimura, Robert B. Jaffe

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Context: In the human fetal adrenal gland (HFA), the inner fetal zone (FZ) secretes dehydroepiandrosterone sulfate. The function of the outer definitive zone (DZ) is less clear; however, the DZ phenotype is that of a reservoir of progenitor cells, many of which are mitotically active. Midkine (MK) is a heparin-binding growth factor with various bioactivities. Objective: The objective of this study was to investigate expression, proliferative effects, and ACTH regulation of MK in the HFA. Design and Setting: RNA, cryosections, and primary cell cultures from HFAs (14-24 wk) and adult adrenal RNA were used. Main Outcome Measures: The main outcome measures were MK mRNA levels (measured by quantitative real-time RT-PCR); MK localization (measured by immunostaining); MK proliferative effects and mechanism (measured by proliferation assays, flow cytometry, pharmacological interventions); and ACTH regulation (measured by quantitative real-time RT-PCR). Results: HFA MK mRNA levels were 4-fold higher than in adult adrenals (P < 0.05) and were comparable to levels in fetal and adult brains (positive controls). MK immunoreactivity was abundant throughout the HFA. Exogenous MK caused proliferation of isolated DZ cells but not FZ cells (72 h, P < 0.05). In contrast, basic fibroblast growth factor induced proliferation of cells from both zones. Pharmacological interventions indicated that MK-induced DZ cell proliferation may be mediated by phosphatidylinositol 3-kinase, MAPK kinase, and Src family kinases. ACTH (1 nM) increased MK mRNA by 3.5-fold (48 h, P < 0.01) in isolated FZ cells. Conclusions: MK likely plays a key role in HFA development. MK's selective in vitro mitotic effects on DZ cells may provide insights into the mechanism underlying the distinct in vivo differences in mitotic activity between the DZ and FZ.

Original languageEnglish
Pages (from-to)4050-4056
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume91
Issue number10
DOIs
Publication statusPublished - 2006 Oct

Fingerprint

Adrenal Glands
Heparin
Intercellular Signaling Peptides and Proteins
Cells
Adrenocorticotropic Hormone
Messenger RNA
Real-Time Polymerase Chain Reaction
midkine
Cell Proliferation
Outcome Assessment (Health Care)
Phosphatidylinositol 3-Kinase
Pharmacology
RNA
Dehydroepiandrosterone Sulfate
Primary Cell Culture
src-Family Kinases
Flow cytometry
Mitogen-Activated Protein Kinase Kinases
Cell proliferation
Fibroblast Growth Factor 2

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Midkine, a heparin-binding growth factor, selectively stimulates proliferation of definitive zone cells of the human fetal adrenal gland. / Ishimoto, Hitoshi; Muench, Marcus O.; Higuchi, Takayuki; Minegishi, Kazuhiro; Tanaka, Mamoru; Yoshimura, Yasunori; Jaffe, Robert B.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 91, No. 10, 10.2006, p. 4050-4056.

Research output: Contribution to journalArticle

Ishimoto, Hitoshi ; Muench, Marcus O. ; Higuchi, Takayuki ; Minegishi, Kazuhiro ; Tanaka, Mamoru ; Yoshimura, Yasunori ; Jaffe, Robert B. / Midkine, a heparin-binding growth factor, selectively stimulates proliferation of definitive zone cells of the human fetal adrenal gland. In: Journal of Clinical Endocrinology and Metabolism. 2006 ; Vol. 91, No. 10. pp. 4050-4056.
@article{f8f26983e17b4d059e2f4827f8dbc58a,
title = "Midkine, a heparin-binding growth factor, selectively stimulates proliferation of definitive zone cells of the human fetal adrenal gland",
abstract = "Context: In the human fetal adrenal gland (HFA), the inner fetal zone (FZ) secretes dehydroepiandrosterone sulfate. The function of the outer definitive zone (DZ) is less clear; however, the DZ phenotype is that of a reservoir of progenitor cells, many of which are mitotically active. Midkine (MK) is a heparin-binding growth factor with various bioactivities. Objective: The objective of this study was to investigate expression, proliferative effects, and ACTH regulation of MK in the HFA. Design and Setting: RNA, cryosections, and primary cell cultures from HFAs (14-24 wk) and adult adrenal RNA were used. Main Outcome Measures: The main outcome measures were MK mRNA levels (measured by quantitative real-time RT-PCR); MK localization (measured by immunostaining); MK proliferative effects and mechanism (measured by proliferation assays, flow cytometry, pharmacological interventions); and ACTH regulation (measured by quantitative real-time RT-PCR). Results: HFA MK mRNA levels were 4-fold higher than in adult adrenals (P < 0.05) and were comparable to levels in fetal and adult brains (positive controls). MK immunoreactivity was abundant throughout the HFA. Exogenous MK caused proliferation of isolated DZ cells but not FZ cells (72 h, P < 0.05). In contrast, basic fibroblast growth factor induced proliferation of cells from both zones. Pharmacological interventions indicated that MK-induced DZ cell proliferation may be mediated by phosphatidylinositol 3-kinase, MAPK kinase, and Src family kinases. ACTH (1 nM) increased MK mRNA by 3.5-fold (48 h, P < 0.01) in isolated FZ cells. Conclusions: MK likely plays a key role in HFA development. MK's selective in vitro mitotic effects on DZ cells may provide insights into the mechanism underlying the distinct in vivo differences in mitotic activity between the DZ and FZ.",
author = "Hitoshi Ishimoto and Muench, {Marcus O.} and Takayuki Higuchi and Kazuhiro Minegishi and Mamoru Tanaka and Yasunori Yoshimura and Jaffe, {Robert B.}",
year = "2006",
month = "10",
doi = "10.1210/jc.2006-1139",
language = "English",
volume = "91",
pages = "4050--4056",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - Midkine, a heparin-binding growth factor, selectively stimulates proliferation of definitive zone cells of the human fetal adrenal gland

AU - Ishimoto, Hitoshi

AU - Muench, Marcus O.

AU - Higuchi, Takayuki

AU - Minegishi, Kazuhiro

AU - Tanaka, Mamoru

AU - Yoshimura, Yasunori

AU - Jaffe, Robert B.

PY - 2006/10

Y1 - 2006/10

N2 - Context: In the human fetal adrenal gland (HFA), the inner fetal zone (FZ) secretes dehydroepiandrosterone sulfate. The function of the outer definitive zone (DZ) is less clear; however, the DZ phenotype is that of a reservoir of progenitor cells, many of which are mitotically active. Midkine (MK) is a heparin-binding growth factor with various bioactivities. Objective: The objective of this study was to investigate expression, proliferative effects, and ACTH regulation of MK in the HFA. Design and Setting: RNA, cryosections, and primary cell cultures from HFAs (14-24 wk) and adult adrenal RNA were used. Main Outcome Measures: The main outcome measures were MK mRNA levels (measured by quantitative real-time RT-PCR); MK localization (measured by immunostaining); MK proliferative effects and mechanism (measured by proliferation assays, flow cytometry, pharmacological interventions); and ACTH regulation (measured by quantitative real-time RT-PCR). Results: HFA MK mRNA levels were 4-fold higher than in adult adrenals (P < 0.05) and were comparable to levels in fetal and adult brains (positive controls). MK immunoreactivity was abundant throughout the HFA. Exogenous MK caused proliferation of isolated DZ cells but not FZ cells (72 h, P < 0.05). In contrast, basic fibroblast growth factor induced proliferation of cells from both zones. Pharmacological interventions indicated that MK-induced DZ cell proliferation may be mediated by phosphatidylinositol 3-kinase, MAPK kinase, and Src family kinases. ACTH (1 nM) increased MK mRNA by 3.5-fold (48 h, P < 0.01) in isolated FZ cells. Conclusions: MK likely plays a key role in HFA development. MK's selective in vitro mitotic effects on DZ cells may provide insights into the mechanism underlying the distinct in vivo differences in mitotic activity between the DZ and FZ.

AB - Context: In the human fetal adrenal gland (HFA), the inner fetal zone (FZ) secretes dehydroepiandrosterone sulfate. The function of the outer definitive zone (DZ) is less clear; however, the DZ phenotype is that of a reservoir of progenitor cells, many of which are mitotically active. Midkine (MK) is a heparin-binding growth factor with various bioactivities. Objective: The objective of this study was to investigate expression, proliferative effects, and ACTH regulation of MK in the HFA. Design and Setting: RNA, cryosections, and primary cell cultures from HFAs (14-24 wk) and adult adrenal RNA were used. Main Outcome Measures: The main outcome measures were MK mRNA levels (measured by quantitative real-time RT-PCR); MK localization (measured by immunostaining); MK proliferative effects and mechanism (measured by proliferation assays, flow cytometry, pharmacological interventions); and ACTH regulation (measured by quantitative real-time RT-PCR). Results: HFA MK mRNA levels were 4-fold higher than in adult adrenals (P < 0.05) and were comparable to levels in fetal and adult brains (positive controls). MK immunoreactivity was abundant throughout the HFA. Exogenous MK caused proliferation of isolated DZ cells but not FZ cells (72 h, P < 0.05). In contrast, basic fibroblast growth factor induced proliferation of cells from both zones. Pharmacological interventions indicated that MK-induced DZ cell proliferation may be mediated by phosphatidylinositol 3-kinase, MAPK kinase, and Src family kinases. ACTH (1 nM) increased MK mRNA by 3.5-fold (48 h, P < 0.01) in isolated FZ cells. Conclusions: MK likely plays a key role in HFA development. MK's selective in vitro mitotic effects on DZ cells may provide insights into the mechanism underlying the distinct in vivo differences in mitotic activity between the DZ and FZ.

UR - http://www.scopus.com/inward/record.url?scp=33749549654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749549654&partnerID=8YFLogxK

U2 - 10.1210/jc.2006-1139

DO - 10.1210/jc.2006-1139

M3 - Article

VL - 91

SP - 4050

EP - 4056

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 10

ER -